| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $219.0K | $368.1K | $1.5M |
| YoY Revenue Growth % | -40.5% | -75.3% | — |
| Gross Profit | $83.2K | -$167.6K | — |
| Gross Margin % | 38.0% | -45.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$25.7M | -$22.8M | -$23.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$23.5M | -$33.3M | -$22.8M |
| EBITDA (Normalized) | -$24.7M | -$22.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$23.6M | -$19.2M | -$19.5M |
| Capital Expenditures (CapEx) | $1.2M | $1.1M | — |
| Free Cash Flow (FCF) | -$24.8M | -$20.2M | -$19.5M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $990.0K | $23.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $38.8M | -$1.0M | — |